Article may be outdated

This article is 6 days old. Some details may have changed since publication.

American College of Allergy Asthma and Immunology·3 min read·medium

Insurance Delays and Denials Mean Kids Don’t Get Allergy and Asthma Medications

Insurance Delays and Denials Mean Kids Don’t Get Allergy and Asthma Medications
✦AI Summary

A new study presented at the ACAAI meeting reveals that 40% of insurance requests for pediatric biologic medications are denied. These delays in the prior authorization process often leave children with uncontrolled asthma and allergies for weeks.

Why it matters

The findings highlight systemic barriers in the healthcare system that prevent children from accessing necessary, life-improving treatments.

✦Dive DeeperCreate a free account to unlock

New study finds about 4 in 10 requests for children’s biologic medications were denied

PHOENIX (Nov. 12, 2026) – When a child’s severe asthma , eczema , hives, or food allergy isn’t under control, an allergist may prescribe a newer type of medicine called a biologic. But a new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting finds that getting insurance to pay for these medicines can take weeks, and many requests are turned down.

Biologics are medicines, usually given as shots, that target the part of the immune system that causes allergic disease. They can help children whose symptoms don’t get better with other treatments. Before insurance will pay for a biologic, a doctor’s office usually must get prior authorization – requesting permission from the insurance company to order the medication.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in